Summary
GE HealthCare Technologies Inc. (GEHC) announced on September 12, 2024, the commencement and pricing of an underwritten offering of 15,000,000 shares of its common stock at $86.00 per share. It is crucial for investors to note that GEHC itself is not selling any shares and will not receive any proceeds from this offering or an associated debt-for-equity exchange. The shares being offered are currently held by GE Aerospace, which is expected to exchange them for its own indebtedness held by Morgan Stanley Bank, N.A. and Morgan Stanley Senior Funding, Inc. prior to the closing of the offering. Following this debt-for-equity exchange, Morgan Stanley & Co. LLC, acting as the selling stockholder, intends to sell these GEHC shares to the underwriters. This transaction primarily facilitates the divestiture of GE Aerospace's stake in GEHC and a debt reduction for GE Aerospace, without direct capital infusion into GEHC. Investors should monitor the completion of this offering and the subsequent market performance of GEHC shares.
Key Highlights
- 1GEHC announced an underwritten offering of 15,000,000 shares of common stock at $86.00 per share.
- 2GEHC will not receive any proceeds from the sale of these shares.
- 3The shares are being sold by Morgan Stanley & Co. LLC, as the selling stockholder, after GE Aerospace exchanges them for its indebtedness.
- 4This transaction is part of a debt-for-equity exchange involving GE Aerospace and Morgan Stanley.
- 5Underwriters have been granted an option to purchase an additional 2,250,000 GEHC shares.
- 6The offering involves GE Aerospace, Morgan Stanley, and Citigroup Global Markets Inc. as underwriters.